These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

487 related items for PubMed ID: 29572705

  • 1. Is Low-Volume Disease in the Sentinel Node After Neoadjuvant Chemotherapy an Indication for Axillary Dissection?
    Moo TA, Edelweiss M, Hajiyeva S, Stempel M, Raiss M, Zabor EC, Barrio A, Morrow M.
    Ann Surg Oncol; 2018 Jun; 25(6):1488-1494. PubMed ID: 29572705
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. The evolution of the sentinel node procedure in the treatment of breast cancer.
    Tvedskov TF.
    Dan Med J; 2017 Oct; 64(10):. PubMed ID: 28975889
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Clipping the Positive Lymph Node in Patients with Clinically Node Positive Breast Cancer Treated with Neoadjuvant Chemotherapy: Impact on Axillary Surgery in the ISPY-2 Clinical Trial.
    Switalla KM, Boughey JC, Dimitroff K, Yau C, Ladores V, Yu H, Tchou J, Golshan M, Ahrendt G, Postlewait LM, Piltin M, Reyna CR, Matsen CB, Tuttle TM, Wallace AM, Arciero CA, Lee MC, Tseng J, Son J, Rao R, Sauder C, Naik A, Howard-McNatt M, Lancaster R, Norwood P, Esserman LJ, Mukhtar RA.
    Ann Surg Oncol; 2024 Oct; 31(11):7249-7259. PubMed ID: 38995451
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Intraoperative Touch Imprint Cytology in Targeted Axillary Dissection After Neoadjuvant Chemotherapy for Breast Cancer Patients with Initial Axillary Metastasis.
    Wu S, Wang Y, Zhang N, Li J, Xu X, Shen J, Liu G.
    Ann Surg Oncol; 2018 Oct; 25(11):3150-3157. PubMed ID: 30083833
    [Abstract] [Full Text] [Related]

  • 10. Impact of Residual Nodal Disease Burden on Technical Outcomes of Sentinel Lymph Node Biopsy for Node-Positive (cN1) Breast Cancer Patients Treated with Neoadjuvant Chemotherapy.
    Laws A, Hughes ME, Hu J, Barry WT, Dominici L, Nakhlis F, Barbie T, Duggan M, Weiss A, Rhei E, Carter K, Nimbkar S, Schnitt SJ, King TA.
    Ann Surg Oncol; 2019 Nov; 26(12):3846-3855. PubMed ID: 31222687
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Sentinel lymph node surgery after neoadjuvant chemotherapy in patients with node-positive breast cancer: the ACOSOG Z1071 (Alliance) clinical trial.
    Boughey JC, Suman VJ, Mittendorf EA, Ahrendt GM, Wilke LG, Taback B, Leitch AM, Kuerer HM, Bowling M, Flippo-Morton TS, Byrd DR, Ollila DW, Julian TB, McLaughlin SA, McCall L, Symmans WF, Le-Petross HT, Haffty BG, Buchholz TA, Nelson H, Hunt KK, Alliance for Clinical Trials in Oncology.
    JAMA; 2013 Oct 09; 310(14):1455-61. PubMed ID: 24101169
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. The intraoperative assessment of sentinel nodes - Standards and controversies.
    van der Noordaa MEM, Vrancken Peeters MTFD, Rutgers EJT.
    Breast; 2017 Aug 09; 34 Suppl 1():S64-S69. PubMed ID: 28673534
    [Abstract] [Full Text] [Related]

  • 15. The Sentinel Node with Isolated Breast Tumor Cells or Micrometastases. Benefits and Risks of Axillary Dissection.
    Madekivi V, Boström P, Aaltonen R, Vahlberg T, Salminen E.
    Anticancer Res; 2017 Jul 09; 37(7):3757-3762. PubMed ID: 28668871
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Axillary treatment of patients with breast cancer and micrometastatic disease in the sentinel lymph node Our experience.
    Morlino A, La Torre G, Patitucci G, Cammarota A.
    Ann Ital Chir; 2017 Jul 09; 88():360-364. PubMed ID: 29051403
    [Abstract] [Full Text] [Related]

  • 18. Does the presence of sentinel lymph node macrometastases in breast cancer patients require axillary lymph node dissection?-Single-center analysis.
    Nowikiewicz T, Zegarski W, Pagacz K, Nowacki M, Morawiec-Sztandera A, Głowacka-Mrotek I, Sowa M, Biedka M, Kołacińska A.
    Breast J; 2018 Sep 09; 24(5):724-729. PubMed ID: 29476570
    [Abstract] [Full Text] [Related]

  • 19. Decreasing Use of Axillary Dissection in Node-Positive Breast Cancer Patients Treated with Neoadjuvant Chemotherapy.
    Nguyen TT, Hoskin TL, Day CN, Degnim AC, Jakub JW, Hieken TJ, Boughey JC.
    Ann Surg Oncol; 2018 Sep 09; 25(9):2596-2602. PubMed ID: 29978369
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.